What is Whitehawk Therapeutics, Inc. Common Stock's Market Cap?

Whitehawk Therapeutics, Inc. Common Stock's Market Cap is $232.0M, based on as-reported figures from SEC (XBRL) filings.

What is Whitehawk Therapeutics, Inc. Common Stock's Enterprise Value?

Whitehawk Therapeutics, Inc. Common Stock's Enterprise Value is $42.0M, based on as-reported figures from SEC (XBRL) filings.

What is Whitehawk Therapeutics, Inc. Common Stock's EV / EBITDA?

Whitehawk Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Whitehawk Therapeutics, Inc. Common Stock's Revenue (TTM)?

Whitehawk Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Whitehawk Therapeutics, Inc. Common Stock's Net Income (TTM)?

Whitehawk Therapeutics, Inc. Common Stock's Net Income (TTM) is -$79.8M, based on as-reported figures from SEC (XBRL) filings.

What is Whitehawk Therapeutics, Inc. Common Stock's EBITDA?

Whitehawk Therapeutics, Inc. Common Stock's EBITDA is -$86.0M, based on as-reported figures from SEC (XBRL) filings.

What is Whitehawk Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Whitehawk Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.40, based on as-reported figures from SEC (XBRL) filings.

What is Whitehawk Therapeutics, Inc. Common Stock's Net Debt?

Whitehawk Therapeutics, Inc. Common Stock's Net Debt is -$190.0M, based on as-reported figures from SEC (XBRL) filings.

Whitehawk Therapeutics, Inc. Common Stock (WHWK) Financial Statements

Whitehawk Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002WN7DV9

XNAS · usd

4.07▼ 0.12 (-2.86%)

As of 2026-09-10

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close4.19

Day's Range3.99 – 4.18

52-Week Range1.78 – 5.50

Volume1.3M

Avg Volume347.4K

Share Statistics

Shares Outstanding

Employees23

ExchangeXNAS

Listed2021-08-27

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Whitehawk Therapeutics, Inc. Common Stock (WHWK)

What is Whitehawk Therapeutics, Inc. Common Stock's Market Cap?: Whitehawk Therapeutics, Inc. Common Stock's Market Cap is $232.0M, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Enterprise Value?: Whitehawk Therapeutics, Inc. Common Stock's Enterprise Value is $42.0M, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's EV / EBITDA?: Whitehawk Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Revenue (TTM)?: Whitehawk Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Net Income (TTM)?: Whitehawk Therapeutics, Inc. Common Stock's Net Income (TTM) is -$79.8M, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's EBITDA?: Whitehawk Therapeutics, Inc. Common Stock's EBITDA is -$86.0M, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Whitehawk Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.40, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Net Debt?: Whitehawk Therapeutics, Inc. Common Stock's Net Debt is -$190.0M, based on as-reported figures from SEC (XBRL) filings.